eprintid: 36578 rev_number: 13 eprint_status: archive userid: 5878 dir: disk0/00/03/65/78 datestamp: 2025-05-16 11:52:43 lastmod: 2025-05-27 12:33:49 status_changed: 2025-05-16 11:52:43 type: article metadata_visibility: show creators_name: Riedel, Fabian creators_name: Hahn, Markus creators_name: Bader, Werner creators_name: Schäfgen, Benedikt creators_name: Fastner, Sarah creators_name: Hennigs, André creators_name: Gomez, Christina creators_name: Stieber, Anne creators_name: Fastner, Christian creators_name: Wallwiener, Markus creators_name: Golatta, Michael creators_name: Heil, Jörg creators_name: Fallenberg, Eva Maria title: Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German Experts ispublished: pub subjects: ddc-610 divisions: i-61000 divisions: i-65000 divisions: i-910400 keywords: Breast, Biopsy, Anti-coagulation, Anti-platelet therapy, Expert survey note: Dieser Beitrag ist aufgrund einer (DFG-geförderten) Allianz bzw. Nationallizenz frei zugänglich. *** This publication is freely accessible due to an Alliance licence and a national licence (funded by the DFG, German Research Foundation) respectively. abstract: Introduction: Pre-therapeutic histologic diagnosis through image-guided core needle biopsy (CNB) or vacuum-assisted biopsy (VAB) for suspicious breast findings is a standard procedure. Despite the moderate risk of bleeding, a significant proportion of patients are on temporary or permanent anti-coagulation therapy (ACT) or anti-platelet therapy (APT). Currently, there are no established guidelines for managing biopsies in such patients, leading to varying approaches in clinical practice. Methods: An online survey was conducted among all members of the breast ultrasound working group at the German Society for Ultrasound in Medicine (DEGUM) and the working group for breast diagnostics at the German Radiology Society (DRG). It included n = 51 questions about individual risk perception of biopsy-related bleeding complications and the specific management of biopsies on ACT/APT. Results: A total of 332 experts participated, with 51.8% reporting the absence of a standardized management plan for breast biopsies on ACT/APT. Concerning specific ACT/APT medications, the survey revealed discrepancies in risk perception and management: The majority preferred discontinuing medication with directly acting oral anti-coagulants (DOACs; CNB: 66.9%; VAB: 91.1%), phenprocoumon (CNB: 74.9%; VAB: 96.7%), or therapeutic heparin (CNB: 46.1%; VAB: 72.7%). However, there was a lower inclination to discontinue acetylsalicylic acid (ASA; CNB: 15.2%; VAB: 50.3%) or prophylactic heparin (CNB: 11.9%, VAB: 36.3%). Conclusion: Breast biopsies for patients on ASA or prophylactic heparin are deemed safe and part of standard clinical practice. However, despite available feasibility studies, conducting breast biopsies on ACT medications such as DOACs or phenprocoumon appears feasible only for a minority of experts. date: 2024 date_type: published publisher: Karger id_scheme: DOI id_number: 10.11588/heidok.00036578 official_url: https://doi.org/10.1159/000536079 ppn_swb: 1926870395 own_urn: urn:nbn:de:bsz:16-heidok-365783 language: eng bibsort: RIEDELFABIMANAGEMENT2024 full_text_status: public publication: Breast Care volume: 19 number: 2 place_of_pub: Basel ; Freiburg, Br. ; Paris ; London ; New York, NY ; Bangalore ; Bangkok ; Shanghai ; Singapore ; Tokyo ; Sydney pagerange: 87-95 pages: 9 issn: 1661-3791 (Druck-Ausg.); 1661-3805 (Online-Ausg.) edition: Zweitveröffentlichung citation: Riedel, Fabian ; Hahn, Markus ; Bader, Werner ; Schäfgen, Benedikt ; Fastner, Sarah ; Hennigs, André ; Gomez, Christina ; Stieber, Anne ; Fastner, Christian ; Wallwiener, Markus ; Golatta, Michael ; Heil, Jörg ; Fallenberg, Eva Maria (2024) Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German Experts. Breast Care, 19 (2). pp. 87-95. ISSN 1661-3791 (Druck-Ausg.); 1661-3805 (Online-Ausg.) document_url: https://archiv.ub.uni-heidelberg.de/volltextserver/36578/1/BRC536079.pdf